Jane Street’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAC
6CM
Jane Street's RNAC Position: Q3 2026 in Review
Jane Street sold out of Cartesian Therapeutics (RNAC) in Q3 2026, closing a stake of 11,824 shares — an estimated $103K sold.
Jane Street first reported a position in RNAC in Q2 2019 and held it in 16 quarters. The position peaked at $478K in Q2 2020. 80 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.
- Jane Street reported no remaining Cartesian Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jane Street sold 11,824 Cartesian Therapeutics shares in Q3 2026, an estimated $103K.
- Jane Street first reported a position in Cartesian Therapeutics in Q2 2019 and held it in 16 quarters.
- Jane Street's Cartesian Therapeutics position peaked at $478K in Q2 2020.
- 80 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.